Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Irvin Chen
University of California Los Angeles, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Calimmune
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Chen is the PI and will provide overall design and guidance for the proposal. He is a founder of Calimmune, owns equity and is an inventor of IP to be used in this study.
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
PROJECT NARRATIVE Genetic engineering of hematopoietic stem cells is potentially an attractive means to confer life-long resistance to HIV-1 infection. Because of the diverse phenotypic and functional heterogeneity of blood stem cells, the consequences of gene modification of hematopoietic stem cells requires detailed investigation at the clonal level. Page 1 of 1
Filed on September 25, 2014.
Tell us what you know about Irvin Chen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Irvin Chen filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Irvin Chen | University of California Los Angeles | Conflict of Interest | Calimmune (Aquired by CSL Behring) | $550,000 - $599,999 |
| Irvin Chen | University of California Los Angeles | Conflict of Interest | Calimmune | $350,000 - $399,999 |
| Irvin Chen | University of California Los Angeles | Conflict of Interest | Calimmune | Value cannot be readily determined |
| Irvin Chen | University of California Los Angeles | Conflict of Interest | Calimmune | Value cannot be readily determined |
| Irvin Chen | University of California Los Angeles | Conflict of Interest | Calimmune (Aquired by CSL Behring) | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.